Awni Musharbash
Overview
Explore the profile of Awni Musharbash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Hussaini M, Al-Ani A, Amarin J, Al Sharie S, Obeidat M, Musharbash A, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002185
Background And Objectives: Primary central nervous system (CNS) tumors are often associated with relatively poor outcomes. Data on the epidemiology and outcome of CNS tumors in Jordan are scarce. We...
2.
BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country
Abu Laban D, Alsharif A, Al-Hussaini M, Obeidat M, Maraqa B, Alzoubi Q, et al.
Front Oncol
. 2024 Oct;
14:1417484.
PMID: 39399174
Introduction: Most pediatric low-grade-gliomas (LGG) and some high-grade-gliomas (HGG) have alterations in the RAS/MAPK pathway. Promising high tumor response rates were achieved using BRAF/MEK inhibitors, however data on their use...
3.
Amayiri N, Obeidat M, Abu Laban D, Musharbash A, Al-Hussaini M, Maraqa B, et al.
Pediatr Blood Cancer
. 2024 May;
71(8):e31058.
PMID: 38753385
No abstract available.
4.
Amayiri N, Al-Hussaini M, Maraqa B, Alyazjeen S, Alzoubi Q, Musharbash A, et al.
Front Oncol
. 2024 Mar;
14:1329024.
PMID: 38440233
Introduction: Advances in molecular diagnostics led to improved targeted interventions in the treatment of pediatric CNS tumors. However, the capacity to test for these is limited in LMICs, and thus...
5.
Amayiri N, Sarhan N, Yousef Y, Ibrahimi A, Abu-Shanab S, Al-Zebin Z, et al.
Pediatr Blood Cancer
. 2022 Sep;
69(12):e30011.
PMID: 36131594
Background: Pediatric intracranial germ cell tumors (iGCT) are rare, with limited data available from Arabic countries. Methods: We retrospectively reviewed the medical charts of children <18 years diagnosed with iGCT...
6.
Amayiri N, Swaidan M, Ibrahimi A, Hirmas N, Musharbash A, Bouffet E, et al.
JCO Glob Oncol
. 2021 Oct;
7:1442-1453.
PMID: 34609903
Purpose: Medulloblastoma is composed of four clinically and prognostically distinct molecular subgroups (WNT, SHH, group 3, and group 4). However, the clinical implications of these subgroups in the context of...
7.
Amayiri N, Spitaels A, Zaghloul M, Figaji A, Cavalheiro S, Muller H, et al.
Pediatr Blood Cancer
. 2020 Aug;
70(11):e28493.
PMID: 32790146
Pediatric craniopharyngioma is a rare tumor with excellent survival but significant long-term morbidities due to the loco-regional tumor growth or secondary to its treatment. Visual impairment, panhypopituitarism, hypothalamic damage, and...
8.
Jabarkheel R, Amayiri N, Yecies D, Huang Y, Toescu S, Nobre L, et al.
Neuro Oncol
. 2019 Sep;
22(2):290-297.
PMID: 31504816
Background: Cerebellar mutism syndrome (CMS) is a common complication following resection of posterior fossa tumors, most commonly after surgery for medulloblastoma. Medulloblastoma subgroups have historically been treated as a single...
9.
Amayiri N, Swaidan M, Abuirmeileh N, Al-Hussaini M, Tihan T, Drake J, et al.
J Glob Oncol
. 2018 Sep;
4:1-7.
PMID: 30241204
Purpose: The management of central nervous system tumors is challenging in low- and middle-income countries. Little is known about applicability of twinning initiatives with high-income countries in neuro-oncology. In 2004,...
10.
Amayiri N, Swaidan M, Al-Hussaini M, Halalsheh H, Al-Nassan A, Musharbash A, et al.
J Pediatr Hematol Oncol
. 2017 Dec;
40(6):478-482.
PMID: 29200156
Pleomorphic xanthoastrocytoma is a rare brain tumor with unique high frequency of BRAF V600E mutation which is plausible for targeted therapy. The anaplastic variant has generally worse prognosis. We present...